<DOC>
	<DOCNO>NCT02011659</DOCNO>
	<brief_summary>To compare postoperative nausea vomiting ( PONV ) perioperative outcome gynecologic patient undergo laparoscopic surgery schedule administration intravenous Ramosetron hospital stay . - Randomized controlled arm : Placebo versus Ramosetron injection - Administration schedule : immediate postoperative status , 12 hr surgery , 36hrs surgery</brief_summary>
	<brief_title>Long Term Prevention Nausea Vomiting Gynecologic Laparoscopy</brief_title>
	<detailed_description>Surgical outcome include operative time , blood loss , Hb change , postoperative pain , nausea/vomiting scale , time rescue therapy , complication</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Adenomyosis</mesh_term>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<criteria>Age : 18 &lt; = , = &lt; 70 benign gynecologic disease ASAClass III Nodefinite malignancy US , CT/MRI , CA 125 &lt; 500IU/ml Nonsmoker Conversion laparotomy Hx malignancy Smoker Suspicious malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Ramosetron , postoperative nausea vomiting , laparoscopy</keyword>
</DOC>